RNAZ Transcode Therapeutics
- 3.760
- -0.090-2.34%
- 3.830
- +0.070+1.86%
Transcode Therapeutics News
H.C. Wainwright Maintains Transcode Therapeutics(RNAZ.US) With Buy Rating, Cuts Target Price to $20
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
HC Wainwright & Co. Maintains Buy on TransCode Therapeutics, Raises Price Target to $20
Express News | Transcode Therapeutics Inc : H.c. Wainwright Adjusts Target Price to $20 From $3 After Reverse Stock Split
Express News | Transcode Therapeutics Inc - Ttx-Mc138 Shows 66% Inhibition of Mir-10B at 24 Hours After Infusion
Express News | Transcode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results From First Cohort in Phase 1 Ttx-Mc138 Clinical Trial
Peering Into TransCode Therapeutics's Recent Short Interest
Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Sector Update: Health Care Stocks Rise in Late Afternoon Trading
Press Release: TransCode Therapeutics, Inc. Announces $8 Million Private Placement
TransCode Therapeutics Announces 1-for-33 Reverse Stock Split
Transcode Therapeutics Reports Increased Losses Amid Funding Challenges
Transcode Therapeutics | 10-Q: Q3 2024 Earnings Report
TransCode Therapeutics Urges Shareholders To Approve Potential Reverse Stock Split To Maintain Nasdaq Listing Amidst Capital Raising Needs; Vote Scheduled For November 22
TransCode Therapeutics Open Letter to Shareholders
Express News | Transcode Therapeutics Announces Nasdaq Extension to Regain Compliance
H.C. Wainwright Maintains Transcode Therapeutics(RNAZ.US) With Buy Rating, Maintains Target Price $3
TransCode Therapeutics: Pioneering MicroRNA-Based Cancer Therapy With Promising Clinical Progress
Express News | Transcode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 Ttx-Mc138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data
No Data